Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition

Qigesan (QGS) has been used to effectively treat esophageal cancer (EC) for decades in China, but the mechanism by which it suppresses EC metastasis remains unknown. In this study, we examined the effects of QGS on EC cell mobility. Using immunohistochemistry and immunofluorescence, expression of Ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Lingyu, Lu, Xin, Chen, Xuanyu, Wu, Yunyan, Zhang, Yushuang, Shi, Huijuan, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288918/
https://www.ncbi.nlm.nih.gov/pubmed/32432570
http://dx.doi.org/10.18632/aging.103238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288918/
https://www.ncbi.nlm.nih.gov/pubmed/32432570
http://dx.doi.org/10.18632/aging.103238

Ejemplares similares